UnitedHealth Group Stock Surges Past $399 on Strong Earnings Guidance
UnitedHealth Group's stock price has surpassed $399 per share on the New York Stock Exchange as of September 2, 2026. This comes after a strong second quarter in 2026, where the company reported earnings per share (EPS) of $6.38, beating analysts' consensus estimates by $1.44.
The company's fiscal year 2026 guidance for adjusted EPS is set at $19.50 to $20.00, with an average forecast of $19.82 from sell-side analysts. MarketBeat data suggests that the stock is trading at around 20 times the midpoint of this guidance, a valuation level considered supported by the company's earnings momentum.
UnitedHealth Group currently carries a Moderate Buy rating with two Strong Buy recommendations and nineteen Buy ratings from analysts, along with an average target price of $456.56 per share. The company's plans to remove prior authorization requirements in parts of its UnitedHealthcare business have also contributed to the positive sentiment.